10 Most Oversold Stocks to Buy According to Billionaires

4. Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Number of Billionaire Holdings: 11 

Dollar Value of Billionaire Holdings: $409,448,206 

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) designs, manufactures, and markets orthopedic reconstructive products.  Additionally, it sells dental implants, trauma goods, sports medicine, biologics, extremities, and associated surgical supplies.

With a 36% market share in knee implants and a 23% market share in hip implants, the firm dominates the orthopedic industry. Because developing medical implants necessitates a drawn-out FDA approval procedure, which naturally limits competition and creates a barrier to entry, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) also enjoys a competitive market advantage due to its regulatory experience.

Ryan Zimmerman, a BTIG analyst, set a price objective of $123.00 on April 25 and kept his buy rating on the stock unchanged. According to the analyst, the business is well-positioned to reclaim market share thanks to its recent strategic product introductions in the hip replacement industry.

Orthopedic surgeons have given the company’s cutting-edge products—such as the Z1 Triple Taper Stem, HAMMR, and OrthoGrid—generally positive reviews. By strengthening Zimmer Biomet Holdings, Inc. (NYSE:ZBH)’s competitive position, the items can bolster the Buy recommendation.